Genetic cause of rare childhood immune disorders discovered
Scientists have pinpointed genetic changes that can leave children born with little to no immune defense against infection.
May 24, 2024
0
72
Scientists have pinpointed genetic changes that can leave children born with little to no immune defense against infection.
May 24, 2024
0
72
A recent study by WifOR Institute highlights the societal benefits of early intensified treatment for Type 2 diabetes patients in Korea. Over a 10-year period,12% more patients who started combination therapy during the early ...
May 24, 2024
0
1
A team from POSTECH and ImmunoBiome has made a potential breakthrough in the fight against cancer. Their research, published in the May issue of Nature Immunology, explores a dietary-derived bacterial strain, IMB001. This ...
May 17, 2024
0
86
Researchers from the Cardiac Regeneration and Heart Failure Research Group (ICREC) at the Germans Trias i Pujol Research Institute (IGTP) and the Heart Institute of the Germans Trias Hospital (iCor) have found beneficial ...
May 14, 2024
0
0
Even though mortality and hospitalization rates have improved, the quality of life for those living with hypertrophic cardiomyopathy (HCM) can be compromised with limiting symptoms such as exertional dyspnea and decreased ...
May 13, 2024
0
0
A drug that targets a protein known as phosphatidylserine boosted the response rate for hepatocellular carcinoma (HCC) patients receiving immunotherapy without compromising their safety, according to results of a phase two ...
May 3, 2024
0
52
For patients with advanced adrenocortical carcinoma, cabozantinib shows promising efficacy, according to a study published online April 9 in The Lancet Oncology.
Apr 29, 2024
0
1
A specific genetic alteration, known as an ALK fusion, drives non-small cell lung cancer in some patients. This abnormality leads to excessive activity of the ALK protein, a key cancer promoter. These tumors can be treated ...
Apr 16, 2024
0
26
A pilot study led by UCLA Health Jonsson Comprehensive Cancer Center investigators suggests that for people with borderline resectable pancreatic cancer, administrating an immunotherapy drug in combination with chemotherapy ...
Apr 5, 2024
0
2
Researchers from Nijmegen and Newcastle have discovered a new genetic mutation leading to severe combined immune deficiency disorder (SCID). It's the first time a mutation in the proteasome, a molecular shredder, has been ...
Mar 19, 2024
0
14